Pharming Group NV
SWB:PHGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pharming Group NV
SWB:PHGN
|
NL |
|
C
|
Compagnie De l'odet SE
SWB:49F
|
FR |
|
L
|
LY Corp
DUS:YOJ
|
JP |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
S
|
Stef SA
F:STP
|
FR |
|
Majestic Gold Corp
XTSX:MJS
|
CA |
|
W
|
Wilmar International Ltd
OTC:WLMIY
|
SG |
|
S
|
Sumitomo Mitsui Financial Group Inc
F:XMF
|
JP |
|
F
|
Frontier Lithium Inc
OTC:LITOF
|
CA |
|
I
|
Industrial and Commercial Bank of China Ltd
F:ICK
|
CN |
|
Nongfu Spring Co Ltd
HKEX:9633
|
CN |
|
Diebold Nixdorf Inc
NYSE:DBD
|
US |
|
F
|
FIH Mobile Ltd
XMUN:FW3
|
TW |
|
E
|
Ethos Ltd
NSE:ETHOSLTD
|
IN |
|
Venus Concept Inc
NASDAQ:VERO
|
CA |
|
Strides Pharma Science Ltd
NSE:STAR
|
IN |
|
N
|
Norsk Hydro ASA
XHAM:NOH1
|
NO |
|
Schneider Electric SE
PAR:SU
|
FR |
|
A
|
Associated British Foods PLC
XMUN:AFO1
|
UK |
|
A
|
Allkem Ltd
XBER:3O10
|
AU |
|
A
|
AXA SA
PAR:CSNV
|
FR |
|
C
|
Constellation Brands Inc
XMUN:CB1A
|
US |
Bankruptcy Probability
Pharming Group NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pharming Group NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
Pharming Group NV
AEX:PHARM
|
804.1m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pharming Group NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pharming Group NV has total debt of 107.1m USD. This includes both short-term (0 USD) and long-term (107.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
